Literature DB >> 9733033

Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

A C DudokdeWit1, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier.   

Abstract

The first comparative study on predicting post-test distress (conceptualised by intrusion and avoidance, measured with the Impact of Event Scale) after presymptomatic genetic testing for Huntington's disease (HD, n=25), cancer syndromes (familial adenomatous polyposis (FAP, n=23)), and hereditary breast and ovarian cancer (HBOC, n=10) is reported. The variables with the highest predictive potential of post-test distress are presented. Participants who were depressed before the test were more distressed after testing, but we found that those who were anxious before the test were less distressed, that is, had less intrusive thoughts post-test. Other factors associated with a higher level of post-test intrusion were gender (being a woman), having children, and pre-test intrusion. Religion and being at risk for HBOC were associated with less post-test intrusion. Participants who showed avoidance behaviour before the test and those who had many people available for support showed more avoidance behaviour post-test. The test result did not additionally contribute to post-test distress. The prima facie simple notion that the test result, as such, determines the distress experienced seems to be a misrepresentation of the complex reality.

Entities:  

Mesh:

Year:  1998        PMID: 9733033      PMCID: PMC1051427          DOI: 10.1136/jmg.35.9.745

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  63 in total

1.  Uptake of presymptomatic predictive testing for Huntington's disease.

Authors:  D Craufurd; A Dodge; L Kerzin-Storrar; R Harris
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

2.  The measurement of pessimism: the hopelessness scale.

Authors:  A T Beck; A Weissman; D Lester; L Trexler
Journal:  J Consult Clin Psychol       Date:  1974-12

3.  Validation of the Impact of Event Scale for psychological sequelae of combat.

Authors:  J Schwarzwald; Z Solomon; M Weisenberg; M Mikulincer
Journal:  J Consult Clin Psychol       Date:  1987-04

4.  Impact of Event Scale: a cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes.

Authors:  N J Zilberg; D S Weiss; M J Horowitz
Journal:  J Consult Clin Psychol       Date:  1982-06

5.  On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.

Authors:  A Tibben; P G Frets; J J van de Kamp; M F Niermeijer; M Vegtervan der Vlis; R A Roos; H G Rooymans; G J van Ommen; F Verhage
Journal:  Am J Med Genet       Date:  1993-07-15

6.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

7.  Impact of Event Scale: a measure of subjective stress.

Authors:  M Horowitz; N Wilner; W Alvarez
Journal:  Psychosom Med       Date:  1979-05       Impact factor: 4.312

8.  Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.

Authors:  M Bloch; M Fahy; S Fox; M R Hayden
Journal:  Am J Med Genet       Date:  1989-02

9.  Social system responses to Huntington disease.

Authors:  S Kessler; M Bloch
Journal:  Fam Process       Date:  1989-03

10.  Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.

Authors:  J Brandt; K A Quaid; S E Folstein; P Garber; N E Maestri; M H Abbott; P R Slavney; M L Franz; L Kasch; H H Kazazian
Journal:  JAMA       Date:  1989-06-02       Impact factor: 56.272

View more
  14 in total

1.  Personal factors associated with reported benefits of Huntington disease family history or genetic testing.

Authors:  Janet K Williams; Cheryl Erwin; Andrew Juhl; James Mills; Bradley Brossman; Jane S Paulsen
Journal:  Genet Test Mol Biomarkers       Date:  2010-08-19

2.  Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.

Authors:  M Decruyenaere; G Evers-Kiebooms; A Boogaerts; J J Cassiman; T Cloostermans; K Demyttenaere; R Dom; J P Fryns
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

3.  Who Is at Risk for Psychological Distress in Genetic Testing Programs for Hereditary Cancer Disorders?

Authors:  F J Grosfeld; C J Lips; F A Beemer; H F Ten Kroode
Journal:  J Genet Couns       Date:  2000-06       Impact factor: 2.537

4.  An extended family suddenly confronted with a life-threatening hereditary arrhythmia.

Authors:  K S W H Hendriks; I M van Langen; J P van Tintelen; F J M Grosfeld; A A M Wilde; H F J Ten Kroode
Journal:  Neth Heart J       Date:  2005-09       Impact factor: 2.380

5.  Disclosure of APOE genotype for risk of Alzheimer's disease.

Authors:  Robert C Green; J Scott Roberts; L Adrienne Cupples; Norman R Relkin; Peter J Whitehouse; Tamsen Brown; Susan LaRusse Eckert; Melissa Butson; A Dessa Sadovnick; Kimberly A Quaid; Clara Chen; Robert Cook-Deegan; Lindsay A Farrer
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

6.  The FAP self-concept scale (adult form).

Authors:  Mary Jane Esplen; Noreen Stuckless; Terri Berk; Kate Butler; Steve Gallinger
Journal:  Fam Cancer       Date:  2008-08-13       Impact factor: 2.375

7.  Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.

Authors:  Brita Arver; Aina Haegermark; Ulla Platten; Annika Lindblom; Yvonne Brandberg
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

8.  Role of the disease in the psychological impact of pre-symptomatic testing for SCA2 and FAP ATTRV30M: Experience with the disease, kinship and gender of the transmitting parent.

Authors:  Milena Paneque; Carolina Lemos; Alda Sousa; Luis Velázquez; Manuela Fleming; Jorge Sequeiros
Journal:  J Genet Couns       Date:  2009-10       Impact factor: 2.537

9.  Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease.

Authors:  Elizabeth Penziner; Janet K Williams; Cheryl Erwin; Yvonne Bombard; Anne Wallis; Leigh J Beglinger; Michael R Hayden; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-04-05       Impact factor: 3.568

10.  Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.

Authors:  Michael R Cassidy; J Scott Roberts; Thomas D Bird; Ellen J Steinbart; L Adrienne Cupples; Clara A Chen; Erin Linnenbringer; Robert C Green
Journal:  Alzheimers Dement       Date:  2008-11       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.